<DOC>
	<DOCNO>NCT00400894</DOCNO>
	<brief_summary>Emerging differential proteomic study sample pair prostate cancer benign tissue , annexin A3 ( ANXA3 ) choose potential novel biomarker early non-invasive diagnosis prostate cancer . We want show investigate , : - ANXA3 detect urine standard digital rectal examination . - ANXA3 good specificity tPSA , particular grey zone PSA - ANXA3 help avoid unnecessary biopsy - ANXA3 long run replace PSA marker</brief_summary>
	<brief_title>Annexin A3 ( ANXA3 ) Protein-Based Marker Non-Invasive Molecular Diagnostics Prostate Carcinoma</brief_title>
	<detailed_description>The aim multi centre double-blinded study investigate specificity sensitivities early detection prostate cancer new protein biomarker , annexin A3 , use urine digital rectal examination/massage ( exprimate urine ) direct comparison correspond measurement gold standard , total PSA . The material obtain non-invasive procedure moreover use determine appropriate cut-off value optimal fraction ( e.g . centrifugation ) calibration quantitative measurement novel marker . Patients ( 500-750 ) ( ) continuously recruit four clinical centre Germany ( Berlin , Tübingen , Ludwigshafen ) Austria ( Innsbruck ) . The major aspect : • Can annexin A3 provide good specificity tPSA , particular grey zone PSA ( 2-10 ng/ml ) annexin A3 thus contribute significant reduction invasive transrectal biopsy ?</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<mesh_term>Carcinoma Situ</mesh_term>
	<mesh_term>Prostatic Intraepithelial Neoplasia</mesh_term>
	<criteria>Patients histological confirmation adenocarcinoma prostate Patients benign prostatic hyperplasia ( confirmed histology lance biopsy TURP ) Patients rectal extirpation Patients renal bladder tumor</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2007</verification_date>
	<keyword>prostate cancer</keyword>
	<keyword>annexin A3</keyword>
	<keyword>early detection</keyword>
	<keyword>exprimate urine</keyword>
</DOC>